600422 昆药集团
已收盘 10-31 15:00:00
资讯
新帖
简况
昆药集团前三季度净利2.69亿元,同比下降39.42%
北京商报 · 10-24
昆药集团前三季度净利2.69亿元,同比下降39.42%
昆药集团(600422)披露公司2025年第四次临时股东大会决议公告,10月10日股价上涨0.57%
证券之星 · 10-10
昆药集团(600422)披露公司2025年第四次临时股东大会决议公告,10月10日股价上涨0.57%
每周股票复盘:昆药集团(600422)渠道改革与集采进展
证券之星 · 08-23
每周股票复盘:昆药集团(600422)渠道改革与集采进展
昆药集团:8月17日投资者关系活动记录,包括知名机构淡水泉,汉和资本的多家机构参与
证券之星 · 08-20
昆药集团:8月17日投资者关系活动记录,包括知名机构淡水泉,汉和资本的多家机构参与
昆药集团股价微跌0.68% 半年度营收33.51亿元
金融界 · 08-19
昆药集团股价微跌0.68% 半年度营收33.51亿元
中报“增收不增利”的华润三九:CHC业务“失速”,“三费”大增挤压利润,昆药集团营利双降“添堵”
证券之星 · 08-19
中报“增收不增利”的华润三九:CHC业务“失速”,“三费”大增挤压利润,昆药集团营利双降“添堵”
昆药集团股价小幅上扬 开源证券给予买入评级
金融界 · 08-18
昆药集团股价小幅上扬 开源证券给予买入评级
东吴证券-昆药集团-600422-2025年半年报点评:多重因素下业绩承压,渠道改革持续蓄能-250818
市场资讯 · 08-18
东吴证券-昆药集团-600422-2025年半年报点评:多重因素下业绩承压,渠道改革持续蓄能-250818
国金证券:给予昆药集团增持评级
证券之星 · 08-17
国金证券:给予昆药集团增持评级
昆药集团(600422)2025年中报简析:净利润减26.88%
证券之星 · 08-16
昆药集团(600422)2025年中报简析:净利润减26.88%
每周股票复盘:昆药集团(600422)股东户数增加,上半年营收下降11.68%
证券之星 · 08-16
每周股票复盘:昆药集团(600422)股东户数增加,上半年营收下降11.68%
华润医药(03320):昆药集团上半年归母净利约1.98亿元,同比减少26.88%
智通财经 · 08-15
华润医药(03320):昆药集团上半年归母净利约1.98亿元,同比减少26.88%
图解昆药集团中报:第二季度单季净利润同比减22.96%
证券之星 · 08-15
图解昆药集团中报:第二季度单季净利润同比减22.96%
昆药集团股份有限公司发布压片机采购公告
DoNews · 08-09
昆药集团股份有限公司发布压片机采购公告
松金市场咨询(北京)有限公司中标昆药集团调研项目
DoNews · 08-08
松金市场咨询(北京)有限公司中标昆药集团调研项目
中药上市公司财务总监PK:昆药集团孙志强薪酬增幅最大 同比涨幅达283.57%
新浪证券 · 08-08
中药上市公司财务总监PK:昆药集团孙志强薪酬增幅最大 同比涨幅达283.57%
中药上市公司财务总监PK:40岁及以下CFO占比12%。 恩威医药胡大伟为业内最年轻CFO
新浪证券 · 08-08
中药上市公司财务总监PK:40岁及以下CFO占比12%。 恩威医药胡大伟为业内最年轻CFO
青蒿素概念盘中跳水,润都股份跌5.21%
市场透视 · 08-08
青蒿素概念盘中跳水,润都股份跌5.21%
中药上市公司董秘PK:益佰制药蒋先洪任董秘一年即收获140万年薪 显著高于行业均值
新浪证券 · 08-01
中药上市公司董秘PK:益佰制药蒋先洪任董秘一年即收获140万年薪 显著高于行业均值
昆药集团:公司有青蒿类原料药业务,相关业务在公司总体营收中占比较小
互动易 · 07-28
昆药集团:公司有青蒿类原料药业务,相关业务在公司总体营收中占比较小
加载更多
公司概况
公司名称:
昆药集团股份有限公司
所属行业:
医药制造业
上市日期:
2000-12-06
主营业务:
昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是昆药血塞通系列、蒿甲醚系列,华润圣火理洫王血塞通软胶囊,昆中药参苓健脾胃颗粒、舒肝颗粒、香砂平胃颗粒,贝克诺顿阿法骨化醇软胶囊、玻璃酸钠注射液、医药流通商业、健康产业、国际化医疗健康服务。公司荣获由证券时报主办的第十六届“中国上市公司投资者关系管理天马奖”。
发行价格:
10.22
{"stockData":{"symbol":"600422","market":"SH","secType":"STK","nameCN":"昆药集团","latestPrice":13.61,"timestamp":1761894000000,"preClose":13.54,"halted":0,"volume":4983560,"delay":0,"changeRate":0.0052,"floatShares":757000000,"shares":757000000,"eps":0.7003,"marketStatus":"已收盘","change":0.07,"latestTime":"10-31 15:00:00","open":13.53,"high":13.63,"low":13.52,"amount":67759400,"amplitude":0.0081,"askPrice":13.62,"askSize":1231,"bidPrice":13.61,"bidSize":31,"shortable":0,"etf":0,"ttmEps":0.7003,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.54,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":14.89,"lowLimit":12.19,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":756975757,"isCdr":false,"pbRate":1.94,"roa":"--","peRate":19.434528,"roe":"5.07%","epsLYR":0.86,"committee":-0.270623,"marketValue":10302000000,"turnoverRate":0.0066,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-11-03。","floatMarketCap":10302000000},"requestUrl":"/m/hq/s/600422","defaultTab":"news","newsList":[{"id":"2577517185","title":"昆药集团前三季度净利2.69亿元,同比下降39.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577517185","media":"北京商报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577517185?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:55","pubTimestamp":1761314100,"startTime":"0","endTime":"0","summary":"北京商报讯(记者丁宁)10月24日晚间,昆药集团(600422)发布2025年三季报显示,公司前三季度营业收入47.51亿元,同比下降18.08%;归属净利润2.69亿元,同比下降39.42%。 针对净利变动的原因,昆药集团表示,主要系公司持续推进模式再造与渠道变革向深水区突破,渠道动能转换期内,销售端面临阶段性承压,叠加全国中成药集采扩围续约执行进度晚于预期、零售药店终端整合等多重因素影响所致。(文章来源:北京商报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-24/doc-infuzhch6700418.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-24/doc-infuzhch6700418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0188","BK0028","600422","BK0060"],"gpt_icon":0},{"id":"2574177409","title":"昆药集团(600422)披露公司2025年第四次临时股东大会决议公告,10月10日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574177409","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574177409?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:47","pubTimestamp":1760107638,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,昆药集团报收于14.08元,较前一交易日上涨0.57%,最新总市值为106.58亿元。近日,昆药集团发布2025年第四次临时股东大会决议公告。公告显示,本次股东大会于2025年10月10日在云南省昆明市国家高新技术开发区科医路166号召开,由董事长吴文多主持。出席会议的股东和代理人共948人,代表有表决权股份总数316,628,271股,占公司有表决权股份总数的41.8280%。本次会议无否决议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0028","BK0060","BK0188","BK0239"],"gpt_icon":0},{"id":"2561589752","title":"每周股票复盘:昆药集团(600422)渠道改革与集采进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2561589752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561589752?lang=zh_cn&edition=full","pubTime":"2025-08-24 04:52","pubTimestamp":1755982331,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘,昆药集团报收于14.39元,较上周的14.57元下跌1.24%。本周,昆药集团8月18日盘中最高价报14.79元。昆药集团当前最新总市值108.93亿元,在中药板块市值排名24/67,在两市A股市值排名1739/5152。报告期内,血塞通口服系列及注射用血塞通冻干产品在二季度恢复同环比增长。自昆药集团加入华润三九以后,公司近 2年在渠道建设、媒介品牌等领域推进多项改革,销售费用已随公司收入体量、业务结构及产品布局有所下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","BK0188","600422"],"gpt_icon":0},{"id":"2560103185","title":"昆药集团:8月17日投资者关系活动记录,包括知名机构淡水泉,汉和资本的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2560103185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560103185?lang=zh_cn&edition=full","pubTime":"2025-08-20 20:04","pubTimestamp":1755691460,"startTime":"0","endTime":"0","summary":"报告期内,血塞通口服系列及注射用血塞通冻干产品在二季度恢复同环比增长。湖北、江西两省自 4月 30日起官宣执行中选结果,其余多数省份计划在 5-7月期间执行,截至目前已有 20余省份发文公布执行时间。答:随着理洫王、络泰营销团队的全面整合,777品牌在 7月启动全面融合,此后,华润圣火将逐步转型为生产单元,专注于专业化的生产建设。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082000039679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600422","BK0188","BK0060","BK0028"],"gpt_icon":0},{"id":"2560113871","title":"昆药集团股价微跌0.68% 半年度营收33.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560113871","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560113871?lang=zh_cn&edition=full","pubTime":"2025-08-19 23:27","pubTimestamp":1755617277,"startTime":"0","endTime":"0","summary":"昆药集团股价报14.59元,较前一交易日下跌0.68%。盘中最高触及14.78元,最低下探14.57元,成交额达2.99亿元。昆药集团是专注于植物药和天然药物研发的医药企业,主要产品包括血塞通系列、青蒿素类药品等。昆药集团近日发布2025年半年度报告,报告显示公司实现营业收入33.51亿元,归母净利润1.98亿元。公司表示二季度运营状况较一季度有所好转,血塞通系列产品销量恢复增长。在全球化布局方面,公司血塞通制剂已获15个国家准入资格。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/19232752549244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600422"],"gpt_icon":0},{"id":"2560168937","title":"中报“增收不增利”的华润三九:CHC业务“失速”,“三费”大增挤压利润,昆药集团营利双降“添堵”","url":"https://stock-news.laohu8.com/highlight/detail?id=2560168937","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560168937?lang=zh_cn&edition=full","pubTime":"2025-08-19 14:50","pubTimestamp":1755586250,"startTime":"0","endTime":"0","summary":"这是华润三九2021年以来首次出现半年度净利润下滑。华润三九表示,净利润有所下降主要由于2024年上半年高基数的影响。证券之星注意到,华润三九费用开支的增加也挤压利润空间。由于CHC业务大幅下滑,拉低整体增速。需要注意的是,被华润三九收购后,昆药集团的营收近乎原地踏步。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025081900020042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0196","600422","BK0175","BK0010","BK0239","BK0183","BK0012","BK0185","000999","BK0028"],"gpt_icon":0},{"id":"2560900553","title":"昆药集团股价小幅上扬 开源证券给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2560900553","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560900553?lang=zh_cn&edition=full","pubTime":"2025-08-18 20:41","pubTimestamp":1755520904,"startTime":"0","endTime":"0","summary":"截至2025年8月18日收盘,昆药集团股价报14.69元,较前一交易日上涨0.82%,成交额达2.97亿元。昆药集团主营业务涵盖中药研发、生产和销售,产品包括血塞通系列、天麻素系列等。公司近年来持续推进渠道改革,并积极参与全国药品集采。开源证券发布研报称,给予昆药集团买入评级,认为公司渠道改革进入关键阶段,2025年下半年集采速度有望加快。风险提示:市场及政策变化风险、产品销售不及预期、新品研发不及预期。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/18204152512131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600422","161027"],"gpt_icon":0},{"id":"2560905388","title":"东吴证券-昆药集团-600422-2025年半年报点评:多重因素下业绩承压,渠道改革持续蓄能-250818","url":"https://stock-news.laohu8.com/highlight/detail?id=2560905388","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560905388?lang=zh_cn&edition=full","pubTime":"2025-08-18 17:26","pubTimestamp":1755509160,"startTime":"0","endTime":"0","summary":"2025年单Q2季度,公司实现收入17.43亿元,归母净利润1.08亿元,扣非归母净利润0.79亿元,环比Q1有所改善。对于集采中选产品,公司进一步拓展销售渠道,提升在各级医疗机构的覆盖率,随着下半年集采执行的推进,公司三七血塞通系列产品有望放量加速。2025年下半年,集采中标产品有望放量,随着渠道改革逐步稳定,下半年业绩有望环比改善,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-08-18/doc-infmkyty9883691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600422","BK0183","BK0188","601555","BK0276","BK0060","BK0012","BK0028","BK0239","BK0009"],"gpt_icon":0},{"id":"2560392153","title":"国金证券:给予昆药集团增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2560392153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560392153?lang=zh_cn&edition=full","pubTime":"2025-08-17 13:20","pubTimestamp":1755408026,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对昆药集团进行研究并发布了研究报告《集采执行晚于预期,下半年趋势有望向好》,给予昆药集团增持评级。 昆药集团 2025年8月15日,公司发布2025年半年报。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家;过去90天内机构目标均价为18.9。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700004032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"gpt_icon":0},{"id":"2560926617","title":"昆药集团(600422)2025年中报简析:净利润减26.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560926617","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560926617?lang=zh_cn&edition=full","pubTime":"2025-08-17 06:01","pubTimestamp":1755381686,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期昆药集团发布2025年中报。根据财报显示,昆药集团净利润减26.88%。截至本报告期末,公司营业总收入33.51亿元,同比下降11.68%,归母净利润1.98亿元,同比下降26.88%。管理费用变动幅度为8.04%,原因:管理职能细化。持有昆药集团最多的基金为富国研究精选灵活配置混合A,目前规模为6.99亿元,最新净值2.867,较上一交易日上涨0.88%,近一年上涨21.23%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700001009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"gpt_icon":0},{"id":"2560925074","title":"每周股票复盘:昆药集团(600422)股东户数增加,上半年营收下降11.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560925074","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560925074?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:39","pubTimestamp":1755376751,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘,昆药集团报收于14.57元,较上周的14.57元上涨0.0%。本周,昆药集团8月12日盘中最高价报14.85元。本周关注点股本股东变化:截至2025年6月30日股东户数为3.94万户,较3月31日增加2665户业绩披露要点:2025年中报显示主营收入33.51亿元,同比下降11.68%公司公告汇总:监事会审议通过2025年半年度报告及聘请2025年度审计机构的议案股本股东变化近日昆药集团披露,截至2025年6月30日公司股东户数为3.94万户,较3月31日增加2665.0户,增幅为7.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"gpt_icon":0},{"id":"2559591697","title":"华润医药(03320):昆药集团上半年归母净利约1.98亿元,同比减少26.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559591697","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559591697?lang=zh_cn&edition=full","pubTime":"2025-08-15 18:47","pubTimestamp":1755254856,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布昆药集团2025年上半年业绩,营业总收入约33.51亿元,同比减少11.68%;上市公司股东应占净利润约1.98亿元,同比减少26.88%;每股基本盈利0.26元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600422","BK0028","BK0060","03320","BK1570","BK0188","BK1191","BK0239"],"gpt_icon":0},{"id":"2559915266","title":"图解昆药集团中报:第二季度单季净利润同比减22.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559915266","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559915266?lang=zh_cn&edition=full","pubTime":"2025-08-15 18:15","pubTimestamp":1755252910,"startTime":"0","endTime":"0","summary":"证券之星消息,昆药集团2025年中报显示,公司主营收入33.51亿元,同比下降11.68%;归母净利润1.98亿元,同比下降26.88%;扣非净利润1.51亿元,同比下降5.57%;其中2025年第二季度,公司单季度主营收入17.43亿元,同比下降6.68%;单季度归母净利润1.08亿元,同比下降22.96%;单季度扣非净利润7904.0万元,同比上升67.7%;负债率46.51%,投资收益-69.46万元,财务费用2310.89万元,毛利率39.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081500036589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"gpt_icon":0},{"id":"2558025195","title":"昆药集团股份有限公司发布压片机采购公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2558025195","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558025195?lang=zh_cn&edition=full","pubTime":"2025-08-09 23:31","pubTimestamp":1754753462,"startTime":"0","endTime":"0","summary":"天眼查App显示,昆药集团股份有限公司于2025年08月08日在广东省发布《昆药集团(珠海横琴)科技有限公司实验室项目-压片机采购公告》。本次采购内容为实验用单冲压片机一台,由采购人昆药集团股份有限公司直接发起,采购项目编号为SJCGXY202508080014,采购内容和范围包括实验用单冲压片机一台,指导甲方安装,乙方自主调试。采购文件获取、响应文件提交及相关流程均通过华润守正采购交易平台线上完成,报价截止时间为2025年08月13日12:00(北京时间)。公告类型为招标公告,目前尚未公布中标供应商及中标金额信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080923321294d9ba02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080923321294d9ba02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0060","600422","BK0188"],"gpt_icon":0},{"id":"2557273075","title":"松金市场咨询(北京)有限公司中标昆药集团调研项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557273075","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557273075?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:06","pubTimestamp":1754658363,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年08月07日,昆药集团股份有限公司发布零售终端调研体系建构项目询价结果公告。公告显示,项目成交供应商为松金市场咨询(北京)有限公司。此次采购属于询价结果公告类型,采购人明确为昆药集团股份有限公司。详细信息未包含中标金额及其他补充内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821071994d7bde6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821071994d7bde6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0188","BK0060","600422"],"gpt_icon":0},{"id":"2557118145","title":"中药上市公司财务总监PK:昆药集团孙志强薪酬增幅最大 同比涨幅达283.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557118145","media":"新浪证券","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557118145?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:08","pubTimestamp":1754622480,"startTime":"0","endTime":"0","summary":" 作为上市公司核心管理层关键成员,财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股CFO数据报告》显示,2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元,平均年薪为81.48万元。其中,目前仍任职的最年轻的上市公司CFO年龄38岁,为恩威医药的胡大伟。 从薪酬变动幅度看,吉林敖东的张淑媛2024年薪酬降幅最大,同比降幅达66.13%;昆药集团的孙志强薪酬增幅最大,同比涨幅达283.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-08-08/doc-infkfuvz9153095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0060","BK4181","600422","PK","BK0239","BK4218","BK0028"],"gpt_icon":0},{"id":"2557748519","title":"中药上市公司财务总监PK:40岁及以下CFO占比12%。 恩威医药胡大伟为业内最年轻CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2557748519","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557748519?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:03","pubTimestamp":1754622180,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股CFO数据报告》显示,2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元,平均年薪为81.48万元。从CFO的年龄分布来看,50岁-60岁CFO是市场的中坚力量,占比共计达到44%;60岁以上的CFO占比为2%;40岁-50岁的CFO群体占比为42%;40岁及以下CFO群体占比为12%。其中,目前仍任职的最年轻的上市公司CFO年龄38岁,为恩威医药的胡大伟。从薪酬分布看,A股中药公司CFO年薪平均值为73.09万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808110403a47c3276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808110403a47c3276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600422","562390","600566","BK0239","301331","561510"],"gpt_icon":0},{"id":"2557515613","title":"青蒿素概念盘中跳水,润都股份跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515613?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:48","pubTimestamp":1754617708,"startTime":"0","endTime":"0","summary":"08月08日,青蒿素概念盘中跳水,截至09点48分,青蒿素概念整体指数下跌1.03%,报1345.260点。从个股上来看,该概念的成分股中,润都股份跌5.21%,华润双鹤、复星医药、浙江医药跌幅居前。从资金上来看,截止发稿,青蒿素概念主力净流入为-4970.75万,其中昆药集团受到资金热捧,主力净流入308.81万;拉长时间线来看,该板块近20日主力资金净流入-12.62亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094828973ac510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094828973ac510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600216","002923","BK0028","BK0188","BK0010","02196","BK0185","BK0175","BK0239","600062","600422","600196"],"gpt_icon":0},{"id":"2556869461","title":"中药上市公司董秘PK:益佰制药蒋先洪任董秘一年即收获140万年薪 显著高于行业均值","url":"https://stock-news.laohu8.com/highlight/detail?id=2556869461","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556869461?lang=zh_cn&edition=full","pubTime":"2025-08-01 13:12","pubTimestamp":1754025120,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股董秘数据报告》显示,2024年A股上市公司董秘薪酬合计达40.86亿元,平均年薪75.43万元。分行业来看,统计数据显示,A股共有69家上市中药公司,董事会秘书聘任总体情况如下。其中,最年轻的上市公司董秘年仅32岁,为特一药业的许紫兰。从薪酬分布看,A股中药上市公司董秘年薪平均值为74.24万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801131303a46ef707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801131303a46ef707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0097","561510","600436","600594","BK0012","600080","BK0039","BK0060","BK0070","562390","BK0239","BK0077","BK0028","BK0096","600566","BK0188","600422"],"gpt_icon":0},{"id":"2554721426","title":"昆药集团:公司有青蒿类原料药业务,相关业务在公司总体营收中占比较小","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721426","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554721426?lang=zh_cn&edition=full","pubTime":"2025-07-28 15:36","pubTimestamp":1753688168,"startTime":"0","endTime":"0","summary":"有投资者向昆药集团提问, 请问贵公司有原料药业务吗?若有的话占公司总体营收占比大概是多少?公司回答表示,尊敬的投资者,您好。公司有青蒿类原料药业务,相关业务在公司总体营收中占比较小。感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728155050a6c57a67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728155050a6c57a67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600422"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761933170022,"stockEarnings":[{"period":"1week","weight":-0.0286},{"period":"1month","weight":-0.0251},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0921},{"period":"1year","weight":-0.0861},{"period":"ytd","weight":-0.1236}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.1109},{"period":"6month","weight":0.2061},{"period":"1year","weight":0.2058},{"period":"ytd","weight":0.1799}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"昆药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"53735人(较上一季度增加36.50%)","perCapita":"14087股","listingDate":"2000-12-06","address":"云南省昆明市五华区国家高新技术产业开发区科医路166号","registeredCapital":"75697万元","survey":" 昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是昆药血塞通系列、蒿甲醚系列,华润圣火理洫王血塞通软胶囊,昆中药参苓健脾胃颗粒、舒肝颗粒、香砂平胃颗粒,贝克诺顿阿法骨化醇软胶囊、玻璃酸钠注射液、医药流通商业、健康产业、国际化医疗健康服务。公司荣获由证券时报主办的第十六届“中国上市公司投资者关系管理天马奖”。","listedPrice":10.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昆药集团,600422,昆药集团股票,昆药集团股票老虎,昆药集团股票老虎国际,昆药集团行情,昆药集团股票行情,昆药集团股价,昆药集团股市,昆药集团股票价格,昆药集团股票交易,昆药集团股票购买,昆药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}